Neovascularization in Tissue Engineering
AbstractA prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis. View Full-Text
Share & Cite This Article
Chung, J.C.-Y.; Shum-Tim, D. Neovascularization in Tissue Engineering. Cells 2012, 1, 1246-1260.
Chung JC-Y, Shum-Tim D. Neovascularization in Tissue Engineering. Cells. 2012; 1(4):1246-1260.Chicago/Turabian Style
Chung, Jennifer C.-Y.; Shum-Tim, Dominique. 2012. "Neovascularization in Tissue Engineering." Cells 1, no. 4: 1246-1260.